Welcome to LookChem.com Sign In|Join Free
  • or
(S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-aminopropanoic acid hydrochloride is a chemical compound classified as an amino acid derivative. It is a white solid with high solubility in water and a molecular weight of 393.91 g/mol. (S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-aminopropanoic acid hydrochloride is widely utilized in biochemical research and pharmaceutical development due to its potential applications in various fields.

212688-53-4

Post Buying Request

212688-53-4 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

212688-53-4 Usage

Uses

Used in Pharmaceutical Development:
(S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-aminopropanoic acid hydrochloride is used as a building block for the synthesis of various peptides and proteins. Its unique structure allows for the creation of complex molecules with specific functions, making it a valuable component in the development of new drugs and therapies.
Used in Cardiovascular Disease Treatment:
In the medical field, (S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-aminopropanoic acid hydrochloride is used as a potential treatment for certain cardiovascular diseases. Its role in these treatments is still under investigation, but its potential benefits make it a promising area of study.
Used in Protein-Protein Interaction Studies:
(S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-aminopropanoic acid hydrochloride is also utilized in research related to protein-protein interactions. Understanding these interactions is crucial for developing a deeper knowledge of cellular processes and can lead to the discovery of new therapeutic targets for various diseases.
Used in Drug Delivery Systems:
(S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-aminopropanoic acid hydrochloride has been found to play a role in the development of drug delivery systems. Its properties make it a suitable candidate for improving the delivery, bioavailability, and therapeutic outcomes of various drugs, particularly in the context of targeted therapies.

Check Digit Verification of cas no

The CAS Registry Mumber 212688-53-4 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 2,1,2,6,8 and 8 respectively; the second part has 2 digits, 5 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 212688-53:
(8*2)+(7*1)+(6*2)+(5*6)+(4*8)+(3*8)+(2*5)+(1*3)=134
134 % 10 = 4
So 212688-53-4 is a valid CAS Registry Number.

212688-53-4Relevant academic research and scientific papers

NITROGEN CONTAINING BICYCLIC COMPOUNDS AND THEIR USE IN TREATMENT OF BACTERIAL INFECTIONS

-

Page/Page column 26; 27, (2017/01/23)

Compounds of Formula (I), their preparation, and use in preventing or treating a bacterial infection are disclosed.

GLUCOSE-RESPONSIVE INSULIN CONJUGATES

-

Page/Page column 150, (2016/10/31)

Insulin conjugates comprising an insulin analog molecule covalently attached to at least one bi-dentate linker having two arms, each arm independently attached to a ligand comprising a saccharide and wherein the saccharide for at least one ligand of the linker is fucose are disclosed. The insulin conjugates display a pharmacokinetic (PK) and/or pharmacodynamic (PD) profile that is responsive to the systemic concentrations of a saccharide such as glucose or alpha-methylmannose even when administered to a subject in need thereof in the absence of an exogenous multivalent saccharide-binding molecule such as Con A.

GLUCOSE-RESPONSIVE INSULIN CONJUGATES

-

Paragraph 0537, (2015/04/21)

Insulin conjugates comprising an insulin molecule covalently attached to at least one bi-dentate linker having two arms, each arm independently attached to a ligand comprising a saccharide and wherein the saccharide for at least one ligand of the linker is fucose are disclosed. The insulin conjugates display a pharmacokinetic (PK) and/or pharmacodynamic (PD) profile that is responsive to the systemic concentrations of a saccharide such as glucose or alpha-methylmannose even when administered to a subject in need thereof in the absence of an exogenous multivalent saccharide-binding molecule such as Con A.

Solid-phase synthesis of amine-bridged cyclic enkephalin analogues via on-resin cyclization utilizing the Fukuyama-Mitsunobu reaction

Rew, Yosup,Goodman, Murray

, p. 8820 - 8826 (2007/10/03)

An efficient solid-phase synthetic route is described for the preparation of 13-membered amine-bridged cyclic enkephalin analogues (ABEs) 1a and 1c-1j (Figure 1) resulting from a sulfonamide-containing peptide whose backbone is bound to a resin. The Fukuyama-Mitsunobu reaction of the 2-nitrobenzenesulfonyl-protected amine bound to the solid support with protected aminoethanol in the presence of triphenylphosphine and diisopropyl azodicarboxylate (DIAD) is utilized to prepare a resin-bound sulfonamide-protected secondary amine. After peptide cyclization, this protected amine functionality becomes the "amine bridge" of the target molecule. In addition, the reagent DIAD was found to be a superior reagent compared to diethyl azodicarboxylate (DEAD) in the solid-phase Fukuyama-Mitsunobu reaction.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 212688-53-4